Nanovectorization of DNA Through Cells Using Protamine Complexation

Journal of Membrane Biology

Volumn 249, Issue 4, 2016, Pages 493-501

  Boukari, Khaoula ^a   Caoduro, Cécile ^a   Kacem, Raoudha ^a   Skandrani, Nadia ^a   Borg, Christophe ^c   Boulahdour, Hatem ^a   Gharbi, Tijani ^a   Delage Mourroux, Régis ^b   Hervouet, Eric ^b   Pudlo, Marc ^d   Picaud, Fabien ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^d France   (France)

Author keywords

Nanovectorization; Protamine; Simulation

Indexed keywords

1,2 DIMYRISTOYL SN GLYCERO 3 PHOSPHORYLCHOLINE; CARBON NANOTUBE; DNA; GLYCEROPHOSPHORYLCHOLINE DERIVATIVE; NANOCARRIER; PROTAMINE; UNCLASSIFIED DRUG; NANOPARTICLE;

ADSORPTION KINETICS; ARTICLE; ARTIFICIAL MEMBRANE; BINDING AFFINITY; COMPLEX FORMATION; DNA BINDING; DNA TRANSFER; DNA VECTOR; ENDOCYTOSIS; GENE TARGETING; HYDROPHOBICITY; INTERNALIZATION; MOLECULAR DYNAMICS; PARTICLE SIZE; PROTEIN STABILITY; ADSORPTION; ANIMAL; CHEMISTRY; CONFORMATION; HUMAN; MOLECULAR MODEL; TRANSPORT AT THE CELLULAR LEVEL;

ADSORPTION; ANIMALS; BIOLOGICAL TRANSPORT; DNA; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR DYNAMICS SIMULATION; NANOPARTICLES; NANOTUBES, CARBON; PARTICLE SIZE; PROTAMINES;

EID: 84961619756     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-016-9890-5     Document Type: Article

References (51)

1. Akdim B, Pachter R, Day PN, Kim SS, Naik RR (2012) On modeling biomolecular surface nonbonded interactions: application to nucleobase adsorption on single-wall carbon nanotube surfaces. Nanotechnology 23:165703
2. Ali-Boucetta H, Al-Jamal KT, McCarthy D, Prato M, Bianco A, Kostarelos K (2008) Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 4:459–461
3. Balhorn R (2007) The protamine family of sperm nuclear proteins. Genome Biol 8:227
4. Bates K, Kostarelos K (2013) Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals. Adv Drug Deliv Rev 65:2023–2033
5. Bhirde AA, Patel V, Gavard J, Zhang G, Sousa AA, Masedunskas A, Leapman RD, Weigert R, Gutkind JS, Rusling JF (2009) Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3:307–316
6. Bhirde AA, Patel S, Sousa AA, Patel V, Molinolo AA, Ji Y, Leapman RD, Gutkind JS, Rusling JF (2010) Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine 5:1535–1546
7. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–679
8. Biegeleisen K (2006) The probable structure of the protamine–DNA complex. J Theor Biol 241:533–540
9. Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2:711e9
10. Buzanea E et al (2002) DNA nanotechnology of carbon nanotube cells: physico-chemical models of self-organization and properties. Mater Sci Eng C 19:41–45
11. Cabello-Aguilar S, Abou Chaaya A, Picaud F, Bechelany M, Pochat-Bohatier C, Yesylevskyy S, Kraszewski S, Bechelany MC, Rossignol F, Balanzat E, Janot JM, Miele P, Dejardin P, Balme S (2014) Experimental and simulation studies of unusual current blockade induced by translocation of small oxidized PEG through a single nanopore. Phys Chem Chem Phys 16:17883–17892
12. Caoduro C, Kacem R, Boukari K, Picaud F, Brachais C-H, Monchaud D, Borg C, Boulahdour H, Gharbi T, Delage-Mourroux R, Hervouet E, Pudlo M (2016) Carbon nanotube—protamine hybrid: evaluation of DNA cell penetration. Carbon 96:742–752
13. Chen X, Lee GS, Zettl A, Bertozzi CR (2004) Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew Chem Int Ed 43:6112–6116
14. Chen J, Chen S, Zhao X, Kuznetsova LV, Wong SS, Ojima I (2008) Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. J Am Chem Soc 130:16778–16785
15. Clavier A, Kraszewski S, Ramseyer C, Picaud F (2013) Insertion kinetics of small nucleotides through single walled carbon nanotube. J Biotechnol 164:13–18
16. Delgado D, del Pozo-Rodríguez A, Solinís MÁ, Rodríguez-Gascón A (2011) Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway. Eur J Pharm Biopharm 79:495–502
17. Dhar S, Liu Z, Thomale JR, Thomale Dai JR, Lippard SJ (2008) Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J Am Chem Soc 130:11467–11476
18. Dovbeshko GI et al (2003) DNA interaction with single-walled carbon nanotubes: a SEIRA study. Chem Phys Lett 372:432–437
19. Dresselhaus M, Dresselhaus G, Avouris P (2001) Carbon nanotubes: synthesis, properties and applications. Nanoscale Res Lett 9:393
20. Dzmitry A et al (2009a) Reversible metal-semiconductor transition of ssDNA-decorated singlewalled carbon nanotubes. Nano Lett 9:1345–1349
21. Dzmitry A et al (2009b) Scanning tunneling microscopy of DNA-wrapped carbon nanotubes. Nano Lett 9:422–426
22. Feazell RP, Nakayama-Ratchford N, Dai H, Lippard SJ (2007) Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design. J Am Chem Soc 129:8438–8439
23. Firme CP, Prabhakar MS, Bandaru R (2010) Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine 6:245–256
24. Huczko A, Lange H, Bystrzejewski M, Baranowski P, Grubek-Jaworska H, Nejman P, Przybylowski T, Czuminska K, Glapinski J, Walton DRM, Kroto HW (2005) Pulmonary toxicity of 1-D nanocarbon materials. Fuller Nanotubes Carbon Nanostruct 13:141–145
25. Hud N, Milanovich FP, Balhornt R (1994) Evidence of novel secondary structure in DNA-bound protamine is revealed by Raman spectroscopy. Biochemistry 33:7528–7535
26. Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354:56–58
27. Kostarelos K, Bianco A, Prato M (2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nano 4:627–633
28. Lacerda L, Bianco A, Prato M, Kostarelos K (2006) Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 56:1460–1470
29. Lacerda L, Russier J, Pastorin G, Herrero MA, Venturelli E, Dumortier H, Al-Jamal KT, Prato M, Kostarelos K, Bianco A (2012) Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 33:3334–3343
30. Lay CL, Liu J, Liu Y (2011) Functionalized carbon nanotubes for anticancer drug delivery. Expert Rev Med Devices 8:561–566
31. Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68:6652–6660
32. MacKerell A, Bashford D, Bellott DRL, Evanseck JD, Field MJ et al (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616
33. Meng L, Zhang X, Lu Q, Fei Z, Dyson PJ (2012) Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials 33:1689–1698
34. Pantarotto D, Briand JP, Prato M, Bianco A (2004) Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb) 1:16–17
35. Park KH, Chhowalla M, Iqbal Z, Sesti F (2003) Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 278:50212–50216
36. Pastorin G (2009) Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option? Pharm Res 26:746–769
37. Pastorin G, Wu W, Wieckowski S, Briand J-P, Kostarelos K, Prato M, Bianco A (2006) Double functionalisation of carbon nanotubes for multimodal drug delivery. Chem Commun 11:1182–1184
38. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinsky T, Radomski M (2005) Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882–893
39. Rao C, Satishkumar B, Govindaraj A, Nath M (2001) Nanotubes Chem Phys Chem 2:78–105
40. Raukas E, Mikelsaar R-H (1999) Are there molecules of nucleoprotamine? BioEssays 21:440–448
41. Saito R, Dresselhaus G, Dresselhaus M (1998) Physical properties of carbon nanotubes. Imperial College Press, London
42. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, Doyle CD, West JL, Billups WE, Ausman KD, Colvin VL (2006) Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161:135–142
43. Scheicher B, Schachner-Nedherer A-L, Zimmer A (2015) Protamine–oligonucleotide-nanoparticles: recent advances in drug delivery and drug targeting. Eur J Pharm Sci 75:54–59
44. Smart SK, Cassady AI, Lu GQ, Martin DJ (2006) The biocompatibility of carbon nanotubes. Carbon 44:1034–1047
45. Sorgi F, Bhattacharya S, Huang L (1997) Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 4:961–968
46. Sucapane A, Cellot G, Prato M, Giugliano M, Parpura V, Ballerini L (2008) Interactions between cultured neurons and carbon, nanotubes: a nanoneuroscience vignette. J Nanoneurosci 1:1–7
47. Tu X, Manohar S, Jagota A, Zheng M (2009) DNA sequence motifs for structure-specific recognition and separation of carbon nanotubes. Nature 460:250–253
48. Varkouhi AK, Foillard S, Lammers T, Schiffelers RM, Doris E, Hennink WE et al (2011) SiRNA delivery with functionalized carbon nanotubes. Int J Pharm 416:419–425
49. Wykes S, Krawetz S (2003) The structural organization of sperm chromatin. J Biol Chem 278:29471–29477
50. Xiongce Z (2007) Simulation of adsorption of DNA on carbon nanotubes. J Am Chem Soc 129:10438–10445
51. Zakaria AB, Picaud F, Rattier T, Pudlo M, Saviot L, Chassagnon RM, Lherminier J, Gharbi T, Micheau O, Herlem RM (2015) Nanovectorization of TRAIL with single wall carbon nanotubes enhances tumor cell killing. Nano Lett 15:891–895